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ABSTRACT 
 Trauma, congenital defects, and tumor resections can result in discontinuity bone defects, 
which are typically treated through bone grafting. Potential limitations, such as donor site 
morbidity, make the development of synthetic implants with similar success to current 
techniques an attractive alternative for the repair of these structural defecits. Due to its chemical 
similarity, porous hydroxyapatite (HA) remains a candidate biomaterial for synthetic bone 
grafting. This thesis investigates a potential method to improve osteointegration of these 
hydroxyapatite bone scaffolds, the delivery of recombinant human bone morphogenetic protein-2 
(rhBMP-2). The objective of this study is to evaluate the effect of rhBMP-2 addition on scaffold 
osteointegration and degradation in a porcine animal model. 
Scaffolds were prepared and inserted into surgically induced defects in the mandibles of 
Yorkshire pigs in order to compare the addition of rhBMP-2-containg hydroxyapatite scaffolds 
to empty hydroxyapatite control scaffolds and hydroxyapatite scaffolds with empty gelatin 
microspheres at 6, 12, 24, and 48 weeks after insertion. Macroscale analysis of bone infiltration 
and scaffold degradation using micro-computed tomography indicated limited differences in 
bone and scaffold amounts between treatments. However, on the microscale, significant 
increases in bone infiltration into scaffold micropores with the rhBMP-2 treatment were 
observed through histological and scanning electron microscope analysis. In addition, significant 
degradation of the scaffold due to the physiological environment could be observed. We 
conclude that addition of rhBMP-2 into a porous hydroxyapatite scaffold may be advantageous 
to bone ingrowth due to improved osteointegration on the microscale. 
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CHAPTER 1                                                                                                      
INTRODUCTION 
1.1 Clinical Rationale 
1.1.1 Current Practices 
Of the 6.8 million bone fractures in the U.S. every year, 5-10% are delayed or non-union 
fractures, which do not heal naturally [1]. Developmental deformities such as cleft palate, tumor 
resections in cases such as oral cancer, and traumatic injuries account for many of these fractures 
[2]. These types of defects affect about 500,000 patients in the U.S. annually. The current 
standard treatment is the autograft, where bone is harvested from a different site in the patient’s 
body, usually the iliac crest in the hip, and shaped by the surgeon to fill the defect. 
Complications occur in 1/3 of all cases, including pain and soreness in the harvested area, as well 
as increased blood loss due to the second surgical site [3]. Another problem is the limited supply 
of bone available, especially for larger defects.  
For these cases, an allograft is typically used in which the bone is taken from a donor, 
usually a cadaver. While removing the problems of the second surgery site, allografts generally 
have limited promotion of bone growth and have the potential for immune rejection leading to 
graft failure [4]. In addition, mechanical weakening occurs due to the required sterilization 
procedure. Alternatives attempt to overcome these disadvantages and include demineralized 
bone proteins [5], platelet gels  [6], and surgical use of bone marrow aspirate [7] to stimulate 
new bone formation. Other alternatives include those used in the tissue engineering approach, 
which include using stem cells, growth factors and synthetic biomaterials. This approach will be 
the focus of this thesis.  
1.1.2 The Bone Tissue Engineering Approach 
The ideal bone graft would be biocompatible without requiring a second surgical site, and 
defects of any size could be repaired without regard to supply. Tissue engineering products 
attempt to directly interact with the host tissue to stimulate regeneration, leveraging the body’s 
natural healing response to an injury [8]. Therefore, bone would potentially be able to retain its 
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ability to repair and remodel itself over the patient’s lifetime and could potentially reduce time in 
surgery with fewer complications. Synthetic scaffolds allow newly forming tissue to obtain the 
proper size and shape, while allowing for substantial control of material properties. Over time, 
these scaffolds will degrade as material is slowly resorbed by the body and replaced by new 
functional tissue [8].   
There are different strategies to accomplish the objectives of tissue engineering 
depending primarily on the amount of cell culture work needed for the therapy. These are the in 
situ, ex vivo, and in vitro strategies [9]. The in situ approach relies on scaffolds and growth 
factors. Ex vivo includes cells expanded in culture and then re-inserted into the patient, and in 
vitro produces most of its tissue in the laboratory bioreactor. For the in situ (in place) strategy, 
stem cells come from the patient and migrate on concentration gradients of inflammatory 
molecules, growth factors, and scaffold degradation particles. They then differentiate into bone 
cells due to the surrounding environment of the wound or directly due to growth factor 
administration. The rate of release of the growth factors to the surrounding tissue is important, as 
the dose of many growth factors determines the cellular response [9].  
For the ex vivo (outside the living) strategy, cells are isolated from a patient or donor. 
After a few weeks, the cell population exponentially increases in culture and is transplanted back 
into the patient through injection into the blood stream or directly at the site of the wound. 
Scaffolds and growth factors can also be included. One potential problem with this method is 
efficiency of migration to the wound, and a risk which would have to be evaluated before clinical 
use would be the possibility of long-term tumor formation. 
For the in vitro (in glass) approach, the challenge in building clinically relevant tissue is 
mass transport [10]. The current standard is to use a flow perfusion bioreactor which circulates 
medium, acting as an artificial circulatory system. However, one complicating factor with bone 
is its mineralized nature, requiring large amounts of blood vessels. Without an effective vascular 
network, large pieces of bone tissue cannot be sustained as the inner portion can become necrotic  
[11]. All three approaches are interconnected and help to inform the other. This thesis focuses on 
the first approach, in situ bone tissue engineering, due to its likelihood of faster translation into 
medical practice, but other methods are definitely important as well. 
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1.1.3 Hydroxyapatite Scaffolds for In Situ Bone Tissue Engineering 
Bone is a composite material of an organic polymer, collagen I, reinforced with mineral 
crystals of impure hydroxyapatite [12]. The ductility and tensile strength of collagen I combined 
with the stiffness and compressive strength of hydroxyapatite give bone balanced mechanical 
properties. The ceramic hydroxyapatite (HA) is of particular interest as a synthetic scaffold 
material due to its chemical similarity to bone, which allows new bone to chemically bond to the 
scaffold, termed bioactive fixation [13]. These strong bonds help to reduce the risk of failure at 
the implant-tissue interface. Hydroxyapatite is osteoconductive, as it encourages bone ingrowth 
when placed adjacent to viable bone. HA also provides a good attachment point for progenitor 
cells, because osteoblasts will selectively adhere to the hydroxyapatite particles [13]. 
Though the degradation rate is generally slower than the rate of new bone formation, on 
the order of months [14], it allows new bone tissue to be filled in as the scaffold slowly dissolves 
away, allowing tissue with the proper shape to remain. Because HA is chemically similar to 
bone, the degradation particles will be similar as well, which may promote a familiar chemical 
environment of ions for cell migration and other functions [15]. These functions make HA a 
strong candidate biomaterial for in situ bone tissue engineering. 
1.2 Recombinant Human Bone Morphogenetic Protein-2 
1.2.1 Biological Activity 
In essence, the process of tissue regeneration is in part a recapitulation of previous 
embryonic development [16]. To direct stem cells down the appropriate path of differentiation 
and promote migration to the correct location, the proper physical and chemical signals in correct 
concentrations are required, such as mechanical loading [17] or growth factors [18].  
Discovered by Urist [19], the bone morphogenetic proteins (BMPs) play an especially 
important role in early tissue morphogenesis through the establishment of concentration 
gradients for cells to migrate toward and away. These BMPs remain in the extracellular matrix 
long after the organism has fully matured. There are 15 proteins currently classified as BMPs by 
amino acid sequence similarities; each is a low molecular weight glycoprotein and each 
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promotes differentiation of a specific cell type. Two of these, BMP-2 and BMP-7 (OP-1), are 
currently considered to be osteoinductive, or able to form bone at an ectopic site [20].  
BMP-2 is especially important in fracture healing due to its key role in osteoblast 
differentiation, attraction of mesenchymal stem cells, and current clinical use [21]. This growth 
factor is biologically active as a dimer and binds to serine threonine kinase cellular receptors. 
Osteoblast differentiation is achieved primarily through the Smad pathway, cascading to the 
eventual upregulation of the transcription factors Runx2, and Osterix. This results in the 
upregulation of genes which are markers of osteoblasts, including alkaline phosphatase, 
osteocalcin and osteopontin, most of which are involved in the calcification of collagen, aiding in 
the formation newly mineralizing bone.  
1.2.2 Current Clinical Uses 
Importantly, the recombinant human form of BMP-2 (rhBMP-2) is commercially 
available. Compared to protein purified from allogenic donors, recombinant BMP-2 generally 
has reduced activity but is generally preferred due to its reduced risk of disease transmission 
[22]. Using mammalian cells to produce the protein allows for higher activity through post-
translational modifications, but is also more costly than using bacterial vectors. One potential 
drawback of this protein is its high production cost; efficacy must be conclusively proven before 
this growth factor will be used widely. 
 rhBMP-2 has been investigated in over 20 clinical trials for bone repair, including lumbar 
spinal fusions, open bone fractures, implant dentistry, avascular necrosis, and bone osteotomy 
procedures [23]. The general consensus of these studies indicates a full or partial 
recommendation for the efficacy of rhBMP-2 to promote enhanced bone healing compared to 
controls. Important outcomes such as duration of surgery, blood loss, hospital stay, reoperation 
rate, median return to work time, and fusion rates showed significant improvement in a majority 
of studies. These clinical trials indicate a future for rhBMP-2, despite its cost, as a potential 
treatment option for patients with conditions requiring enhanced bone repair. 
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1.3 Imaging Methods for Bone Tissue Engineering 
1.3.1 Micro-computed Tomography 
To determine the rate, degree, and location of mineralized tissue ingrowth into scaffolds, 
micro-computed tomography (micro-CT) utilizes the variable X-ray attenuations of different 
materials to image samples [24]. Similar to the CT scans currently used in medicine but with 
finer resolution (µm), X-rays pass through a filter and the sample to form a 2-D projection 
image. Then, the sample is slowly rotated, allowing the capture and output of a series of 2-D 
sliced images. A reconstruction algorithm digitally stacks and aligns these 2-D slices, resulting in 
a 3-D model of the sample which can be used to analyze the two and three-dimensional 
morphological parameters of the scaffold. The process is non-destructive and requires no special 
sample preparation. Computed tomography has some limitations in that the material must be 
radio-opaque, so no single cells can be seen with this method. Also, samples must be small (cm) 
in size.  
Quantitative analysis is possible based on the different attenuation of bone, scaffold and 
background due to their different density and composition [25]. Each volume element, or voxel, 
is assigned a gray scale value. Counting the number of voxels of each gray scale value allows 
distinct histograms to be built. Based on intensity and spatial information, the data can be 
threshholded to label specific voxels as bone, scaffold or background classifications. Because 
this general method is non-destructive and non-invasive, computed tomography will likely be the 
primary method that bone ingrowth is determined once bone tissue engineering scaffold are 
ready for clinical applications. 
1.3.2 Light and Electron Microscope Histology 
As a tissue, bone is composed of two types which differ primarily by porosity. Trabecular 
bone is highly porous and its chief role is in mineral homeostasis and support of blood cell 
formation in the marrow [26]. In comparison, cortical (compact) bone is much less porous and its 
chief role is mechanical support. Cortical bone is constantly being remodeled, in tiny 200 µm 
structures called osteons, by osteoclast resorption and subsequent refilling by osteoblasts. 
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Initially osteoblasts deposit randomly organized collagen fibers to form woven bone. Later, this 
is re-organized into lamellar bone, which is mechanically stronger [26]. 
Histological techniques can analyze this organization by staining and viewing bone tissue 
under a light microscope. Histological techniques, which include formaldehyde fixation, ethanol 
dehydration, poly-methyl methacrylate embedding, diamond saw cutting, and polishing, are 
standard methods. They allow a wide range of features to be studied, including organization of 
collagen fibers, mineralization, and cellular activity [27]. Adding a digital color camera for 
capturing images for analysis with software (Matlab, ImageJ, etc.) allows quantification of the 
amount of mineralizing bone compared to fibrous tissue and evidence of bone remodeling 
cellular activity, angiogenesis and potential necrotic tissue.  
Scanning electron microscopy (SEM) uses a focused electron beam, which continuously 
scans across small areas of the sample [28]. Electrons from the beam displace electrons from the 
sample in each small area, allowing an image to be generated based on the material composition 
and density of the material. Dense ceramics, such as hydroxyapatite, tend to reflect more 
electrons back to the detector than polymers, such as collagen and poly-methyl methacrylate 
used for histological embedding. Detector placement can be close to the beam, detecting 
electrons that reflect (backscatter), or the detector can be angled to the side, detecting deflected 
secondary electrons from the sample (secondary mode). While secondary mode is useful for 
analyzing surface topography, backscatter mode is most useful for compositional analysis of 
bone tissue engineering implants [29]. A wide range of magnifications are possible using SEM 
(100-1,000,000x). Sample preparation requires use of a thin coating of conducting material, such 
as gold or palladium, to ensure electrons do not excessively heat the sample. 
In general, histology is limited to 2-D sections, so significant information is lost in the 
analysis. Sample preparation requires a biopsy of the material so clinical usefulness for treatment 
evaluation could be limited. Taking strengths and drawbacks into account, analysis utilizing 
micro-CT and histological methods in combination can be used to successfully evaluate implant 
success or failure, including quantity of bone ingrowth, scaffold degradation, and integration 
with surrounding bone (osteointegration). 
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1.4 The Pig as a Preclinical Animal Model 
To evaluate the effectiveness of tissue engineering strategies, appropriate large animal 
models are required. One well-established animal model is the pig, which has the advantages of 
availability, rapid growth, low cost, the ability to produce large litters of newborns, and similar 
anatomy and physiology to humans [30]. Pigs are also susceptible to many diseases which occur 
naturally in humans and have been studied for a wide variety of applications, including heart 
surgery, genetic disorders, drug testing, and organ transplantation. Bone biology is similar, 
including intracortical bone remodeling and responses to mechanical, hormonal, or nutritional 
changes and aging [31]. However, the trabecular bone network is very dense compared with 
humans, and menopause does not occur. Therefore, while pigs do not perfectly model human 
physiology, their many advantages and large size make them an attractive model for use in 
preclinical studies. 
Previous work has developed the pig as a craniofacial surgical model in which a total of 
six scaffolds, three per side, can be implanted into the ramus, which is a low-load bearing site on 
the pig’s mandible [32]. This site is also composed of unicortical bone, helping to maintain 
simplicity in the analysis. Pigs possess many qualities which are convenient for surgery, 
including rapid blood clotting, thick skin, and an inability to breathe through their mouth, 
simplifying anesthesia. This model allows for the rapid development and testing of new 
approaches for the repair of damaged bone, which is especially prevalent in the craniofacial area.  
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CHAPTER 2                                                                                                            
IMPLANTATION AND MACROSCALE ANALYSIS  
2.1 Overview 
 This chapter details the scaffold manufacturing process, surgical implantation procedure, 
and protocol for micro-CT analysis in order to determine the amount, location, and rate of bone 
growth into the macropores of the scaffold. Three scaffold types were compared at 6, 12, 24, and 
48 weeks post-implantation. The scaffold types were HA scaffolds without collagen 
microspheres (control), HA scaffolds with empty collagen microspheres, and HA scaffolds with 
collagen microspheres loaded with BMP-2. Findings included limited differences between 
scaffold types over time, with empty gelatin HA scaffolds trending to be higher in bone volume 
fraction than other treatments. In addition, little change in macroporosity was observed over 
time. While the precise explanation is uncertain, it is likely these results are explained in part by 
differences in time and location of bone cell differentiation and subsequent bone production 
during bone defect healing. The hydroxyapatite scaffolds exhibited minimal macroscale 
degradation during the 48-week study. 
2.2 Methods 
2.2.1 Production of hydroxyapatite scaffolds 
Scaffolds were produced from previously characterized, commercially available HA 
powder (Riedel-de Haen, Seelze, Germany). Methods are similar to those used by Lan 
Levengood and Polak, et al. [33,34,35]. Powder was initially 100% HA while heat treatment at 
1300°C resulted in a composition of 87% HA and 13% β-Tricalcium Phosphate (β-TCP). The 
powder was calcined at 1000°C/hr to 1100°C, held for 10 hours, and subsequently cooled to 
ambient temperature to reduce its surface area and improve ease of processing. Calcined powder 
was ball-milled with zirconia ball mill media to reduce the average particle size and break up 
agglomerates. 
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To prepare HA slurry, deioninzed water and Darvan 821A were mixed, with the pH 
adjusted to 10 using 5M NH4OH followed by introduction of HA powder to the solution with 
sonication. The mixture was centrifuged for 60 minutes to concentrate the HA and after 
decanting the supernatant, the concentrated HA suspension was mixed on the paint shaker for  
homogenization. A sample of known mass of the mixture was heated and dried completely to 
determine how close the mixture was to target solids loading (55%). Fugitive porogens of 
PMMA microspheres (Matsumoto Microsphere M-100, Tomen American, New York, NY), 
water, Methocel and 1-octanol were added and the suspension mixed on the paint shaker. The pH 
was adjusted by the incremental addition of 1 M HNO3 to modify slurry viscosity. 
Poly(ethyleneimine) (PEI) gelling agent was added. 
Rectangular lattices were fabricated using micro-robotic deposition [33]. Following 
deposition, lattices were incrementally heated to 900°C to burn out organic materials and 
sintered at 1300°C for 2 hours before cooling to ambient temperature. The samples were 
embedded in wax (McMaster-Carr, Robbinsville, NJ) for machining to yield cylinders with 5 
mm diameter and 8 mm height. Wax was burned out by heating scaffolds at 525°C for 1 hour. 
Scaffolds were autoclaved at 121 C° for 30 min for sterilization prior to being implanted. 
2.2.2 Insertion of BMP-2 and collagen microspheres into scaffolds 
Using similar methods to Lan Levengood et al. [33], gelatin microspheres for growth 
factor delivery were fabricated through a water in-oil emulsion process followed by 
glutaraldehyde crosslinking. Pharmaceutical grade basic gelatin (isoelectric point 9, Nitta Gelatin 
Corp, Osaka, Japan) was dissolved in water (10 wt% solution) and added to 40°C olive oil in a 
solution-to-oil volume ratio of 1:35. At 4°C, an emulsion prepared using a stirrer at 420 rpm and 
the resulting microspheres were washed in cold acetone. Microspheres 20-50 μm in diameter 
were isolated using stainless steel sieves (Fisher Scientific, Pittsburgh, PA). The microspheres 
were crosslinked using 0.5 wt% glutaraldehyde in 0.1% Tween 80 for 24 hours at 4°C. Residual 
glutaraldehyde was quenched with 100 mM glycine and the microspheres washed with 
Millipore-filtered water (Millipore 66 filter, Millipore Corporation, MA). Gelatin microspheres 
in filtered water were frozen in liquid nitrogen for 30 minutes and lyophilized for 48 hours. 
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Microspheres were sterilized with ethylene oxide. This procedure was identical for scaffolds 
filled with rh-BMP-2 and empty gelatin microsphere controls. 
For rh-BMP-2 treatments, rhBMP-2 was reconstituted in sterile 4 mM HCl with 0.1% 
bovine serum albumin (BSA) at a concentration of 0.5 mg/ml. The BMP-2 was allowed to 
infiltrate the basic gelatin microspheres at a ratio of 10 μl BMP-2 solution/1 mg gelatin 
microspheres for 2 hours at room temperature. The ratio of BMP-2 solution volume to gelatin 
microparticle volume was determined in order to yield incomplete saturation of the gelatin 
microspheres. The final dose was 5 μg BMP-2 per 1mg gelatin. The microspheres were 
resuspended in 2 wt% uncrosslinked gelatin at a concentration of 1mg/45 ml. Forty-five (45) ml 
of solution was injected into the top face of the scaffolds to ensure complete macropore 
infiltration. Scaffolds were kept at 4°C until implantation. 
2.2.3 Pre-surgical preparations 
The University of Illinois Institutional Animal Care and Use Committee approved all 
following procedures. Methods are similar to those used by Wilson S.M. et al. Each pig was 
administered the antitbiotic Excede (1cc/44lbs) and AtgardTM as a feed additive 7-10 days prior 
to surgery to eliminate pre-surgical infections.  Before surgery, surgical instruments were 
sterilized by autoclave at 121 °C for 30 min or with ethylene oxide.   
Pigs were verified to be healthy by ability to walk, eat, and normal responses to 
stimulation. They were then moved into the surgery preparation area where they were 
anesthetized with a sedative cocktail (TARK) consisting of Telazol® (tiletamine and 
zolazepam), atropine, xylazine and ketamine before surgery, administered intramuscularly (IM). 
After the first signs of unconsciousness were observed from the IM-administered TARK, the 
balance of the TARK was administered intravenously (IV). The TARK dose was split into 
unequal portions (for example, 6 ml IM, 4 ml IV) depending on the pigs’ weights.   
 Each pig was then placed on their back on a cart for mobility and shoulder length plastic 
gloves were put over the pigs’ feet to minimize fecal contamination. Akwa TearsTM was 
administered to protect the pigs’ eyes.  During the procedures, endotracheal tubes, with the ends 
blunted and smoothed, were inserted into the pigs’ nares (nostrils). Pigs are obligate nose-
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breathers, so no additional tubing was required. A large rubber band was tied around the nose to 
keep tubes in place.   
 Clippers removed most of the hair and debris from the surgical site. After the site was 
clear of obvious dirt, hair and manure, Betadine® scrub was rubbed on the area and a straight 
razor was used for a surgical shave.  The surgical site (mandible) was scrubbed with Betadine® 
and ethanol pads. For each side, the scrub would start in the central area of the surgical site with 
a Betadine® pad, and in a circular motion, would move away from the center.  The process was 
repeated with an ethanol pad. The surgical site was then covered with ZephrinTM solution and 
ethanol pads were placed over the mandible.  
 Using the cart, pigs were moved into the surgery room where they were elevated on the 
surgery table. Oxygen with HalothaneTM was administered through nose tubes, ensuring 
complete unconsciousness. Vital signs, including rectal temperature, blood oxygenation and 
pulse readings, were recorded by a thermometer and pulse oximeter on the tongue in 15 min 
intervals until the pig was sternal post-surgery. Anesthesia and oxygen were monitored 
throughout the surgery. Ethanol pads were removed from the surgical site, and the 
electrocautery-grounding pad was placed on the inner hind leg and plugged it into the control 
module. The electrocautery, suction tube, and drill cord were all plugged into their controllers 
and physiological saline was poured into a sterile surgical bowl for irrigation. 
 At least three people, a surgeon and two assistants, scrubbed in and at least one other 
person was a non-sterile assistant. The surgeon and assistants wore standard surgical equipment, 
including surgical glasses, caps, masks and boot covers before scrubbing. Nails were scrubbed 
with a brush, and hands and arms were washed using Betadine® scrub solution with hot water 
for approximately two minutes. Hands always remained higher than the arm, preventing 
contamination of the hands. Arms were scrubbed above the elbow for one minute. After drying 
with a sterile towel, the surgeon and assistants would be aided to putting on sterile gloves and 
surgical gown.   
2.2.4 Surgical Procedure and Scaffold Implantation 
A sterile IobanTM drape was placed over the surgical area, followed by the placement of 
the sterile thyroid drape.  Sterile scissors were usually needed to cut the drape as a larger area 
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was needed to carry out the surgery.  The incision was marked with a sterile surgical marker.  A 
scalpel with a #10 blade was used to make the initial incision through the skin and an 
electrocautery pencil was used to cut down to the periostium.  Using aseptic surgical technique, 
retromandibular and submandibular incisions were made through the skin and subcutaneous 
tissues to the muscular layer.  The pterygomasseteric sling was incised and the masseter muscle 
was elevated in a subperiosteal plane.  The lateral cortex of the mandible was then exposed from 
the angle superiorly to the level of the condyle and anteriorly to the mental foramina.  Three 
surgical defects were created on each side of the ramus of the mandible (six total per pig), 5 mm 
in diameter.  Using a bur technique with a surgical drill and a 5 mm outer diameter trephine, 
while supplying adequate irrigation, we created the 5 mm defects in the ramus of the mandible. 
The ramus of the mandible was our chosen surgical site due to the flat surfaced, non-weight 
bearing characteristics of that specific area of the mandible. In addition, the mandible is a 
common site for bone grafting in craniomaxillofacial surgery. 
Scaffolds were press-fit into defect sites. Due to small variations in machining, some 
scaffolds broke during fitting. These scaffolds were replaced with extra scaffolds of the same 
treatment. For practicality, one pig received scaffolds of the same treatment type for all six 
defects. Following the implantations, the periosteum was closed over the bone and sutured with 
interrupted vicryl suture followed by similar suturing of the muscle layer. Adipose and skin were 
closed with a continuous Vicryl suture. The skin was then covered with VetbondTM 
cyanoacrylate skin glue. 
2.2.5 Post-surgical recovery 
Following surgery, animals were returned to their individual pens to recover. Rectal 
temperature and breathing was monitored every 15 min until the animal was sternally recumbent. 
A dose of Banamine (2cc/100lbs) was administered 24hr after the surgery and 1 week after 
surgery to provide pain relief, a dose of Excede (1cc/44lbs) was administered to provide broad 
spectrum antibiotic coverage. Every day following the surgery, the pig was thoroughly checked 
twice a day for the first 10 days.  After the first 10 days post-surgery, the pig was thoroughly 
checked once a day.  Checks would include examination of surgical site, physical and social 
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behavior, along with any other medical issues that may have developed.  Pigs were maintained 
on a soft diet for 7-10 days and then resumed a regular dry swine diet until the end of the study. 
2.2.6 Animal Sacrifice 
Pigs were transported by vehicle from Imported Swine Research Laboratory (ISRL) to 
Meat Science Laboratory (MSL) the morning of sacrifice at either 6, 12, 24, or 48 weeks after 
surgery. The pig was electro-stunned and rendered unconscious then was euthanized by 
exsanguination. The entire mandible was removed and cut into two halves (left and right) with a 
hand saw. The mandible was put in a plastic bag which was placed in a styrofoam cooler 
containing ice for transport from MSL to the Mechanical Engineering Building (MEB). 
2.2.7 Sample Collection 
Using a scalpel, tissue was removed, exposing the bone. Each hemi-mandible was 
photographed with a digital camera to record callus formation. To locate the scaffolds (typically 
underneath the callus), bone was polished down until the scaffold became visible. Then scaffolds 
were extracted using a band saw, leaving approximately 1 cm of bone surrounding the scaffold 
on all sides. The samples were placed in 50 ml tubes of cold phosphate-buffered saline (PBS) 
and then transported to the Beckman Institute for micro-computed tomography (micro-CT) 
imaging. 
2.2.8 Micro-CT Imaging 
Freshly harvested scaffolds were scanned with a Skyscan 1172 micro-CT (Skyscan, 
Aartselaar, Belgium). The scanner was operated at 75 kV and 100 mA with a 1mm aluminum 
filter to reduce low energy noise. The medium resolution setting at 95% camera gain was utilized 
so that projection images were taken at 0.4 degree increments over a range of 180 degrees. The 
voxel size was approximately 10 μm. A frame average of five projection images eliminated 
artifacts due to noise from the detector. To help eliminate ring artifacts caused by the detector 
elements, a random vertical movement of 7 was included. The projection radiographs were 16 bit 
TIFF files with 1048 x 2000 pixels. The radiographs were reconstructed using NRecon software 
(Skyscan), which allowed the data to be manipulated as a 3-D object rather than as a projection 
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image. Following reconstruction, the materials with higher attenuations were represented in 
images by higher grayscale values.  
After reconstruction, the data was visualized in 3-D and analyzed by using Amira 5.0 
visualization software (Mercury Computer Systems, Berlin, Germany). The data set of 700 
images was first imported and then data were preprocessed. Background noise was minimized by 
brightness and contrast filtering, the data sets were cropped in order to remove pixels outside of 
the scaffold, and data sets were rotated. For the rotation, the rectangular coordinate system 
natural to the geometry of each of the scaffolds was rotated such that it aligneds with a global 
coordinate system, defined by the horizontal and vertical axes of the computer screen.  
2.2.9 Micro-CT Data Analysis 
After preprocessing, an automated segmentation program, developed by Polak et al. was 
run. The materials were classified into three groups: bone, scaffold, or background (soft tissue) 
in order to calculate the fraction of bone that formed in each scaffold. Each scaffold data set was 
composed of a stack of 700 TIFF images that required segmentation. The program uses grayscale 
information, 3-D spatial features associated with bone and the 3-D periodic structure of the 
scaffold to segment the materials. The program reduced the time from 3-4 hours per individual 
image using manual threshholding, to less than one hour for the entire stack of 700 images in a 
single scaffold. To account for potential differences in trabecular and cortical bone ingrowth, 
image stacks were divided into 3 regions: a top 25% (cortical 1), a middle 50% (trabecular), and 
a lower 25% (cortical 2). 
Briefly, after image segmentation was completed for each scaffold, the resulting 
segmented images are imported back into Amira (Visage Imaging, Carlsbad, CA) for 3-D 
visualization and material volume fraction quantification. Values were calculated as follows for 
each sample: 
 
(1) Bone Volume Fraction  =  volume of total defect space occupied by bone 
   =  (bone pixels) / (total pixels) 
(2) Percent Bone Fill  =  amount of empty space occupied by bone 
    =  (bone pixels) / (bone + background) x 100% 
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(3) Scaffold Macroporosity =  space which is not occupied by scaffold 
    =  1 – (scaffold pixels) / (total pixels) 
2.2.10 Statistical Analysis 
Quantitative data are presented as mean ± standard error. Two-way analysis of 
variance (ANOVA) was performed using SAS statistical analysis software (SAS Institute, Cary, 
NC). Tukey’s test was used for pairwise mean comparisons. A total of 5 scaffolds per treatment 
per timepoint (n=5) were analyzed for a total of 60 scaffolds (N=60). Significance was evaluated 
using an alpha level of 0.05.  
2.3 Results 
2.3.1 Scanning and Reconstruction 
 Representative results for the scanning and reconstruction procedure are shown in Figure 
2.1. In the Amira program, Voltex 3-D representations, while computationally demanding, 
provided the most similar representations to the other original object. Isosurface images were 
useful for rapid object manipulation, such as rotation or cropping. 
2.3.2 Qualitative Comparison of Representative Cross-sections 
 Example 2-D cross-sections for each treatment and time point are shown in Figure 2.2. 
While amount and location of bone varied between scaffolds, a general increase in amount could 
be observed over time across time points. At early time points, the BMP-2 treatment appeared to 
have more bone throughout the scaffold compared to other treatments. However, at later time 
points the controls began to catch up to the BMP-2 treatment. 
2.3.3 Bone Volume Fraction 
 Figure 2.3 shows the results of the measurement for bone volume fraction (volume of 
total defect space occupied by bone). For BMP-2 and empty gelatin treatments, a general 
increase over time could be observed. However, there were statistically significant differences 
between treatments. 
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2.3.4 Percent Bone Fill 
 Figure 2.4 shows results for percent bone fill (amount of empty space occupied by bone). 
A general increase could be observed for all treatments over time. However, no statistical 
differences between treatments could be observed. 
2.3.5 Macroporosity 
 Macroporosity (space not occupied by the scaffold), shown in Figure 2.5, showed 
negligible changes over time compared to non-implanted controls (time 0 wks). This effect was 
consistent for all treatments as well. 
 
 
                 1a     1b    1c 
Figure 2.1: Example of micro-CT scanning and reconstruction procedure. Original scaffold (1a) is 
scanned and saved as series of rotated image stacks (1b). Image stacks are reconstructed into a 3-D 
Voltex representation (1c) in the software program Amira. 
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Figure 2.2: Representative 2-D cross-sections sectioned approximately at midline. Bone (grey, 
irregularly shaped) was present in all scaffolds (brighter, periodic rows) and generally formed near 
scaffold material in varying locations and amounts. Total amount appeared to increase over time 
across treatments with some exceptions.  
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Figure 2.3: Bone volume fraction generally increases over time for all treatments. No significant 
differences were observed between treatments, though scaffolds with empty gelatin microspheres 
trended higher in amount of bone per scaffold, while BMP and empty HA scaffolds are more 
similar. * p < 0.05. 
 
 
Figure 2.4: Percent bone fill is initially highest in the BMP treatment but has more limited increase 
over time than controls. HA reaches a peak at 24 weeks then decreases by 48 weeks, while BMP and 
gelatin controls are more stable over time. * p < 0.05 
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Figure 2.5: Macroporosity displayed negligible change over time for all treatments. 
 
2.4 Discussion 
 Our results demonstrate the relative equivalence between treatments over this timescale 
for important scaffold parameters such as bone infiltration and scaffold degradation on the 
macroscale (>100 µm). Generally, bone infiltrated from the outer perimeter towards the center, 
as could be expected from the normal bone fracture healing process [36]. While the BMP-2 
treated scaffolds had more bone closer to the center of the scaffold at earlier time points (Figure 
2.4), likely due in part to its strong osteoinductive effect on osteoprogenitors [37], this did not 
translate into an increased amount of bone later in the treatment period. Many factors may play a 
role in this key observation, including immediate addition of scaffold treatment following 
osteoectomy, segmentation error in the micro-CT images, and a small but important 
inflammatory reaction to the recombinant human BMP-2 in the pig [38]. However, taking these 
factors into account, normal processes of bone physiology, such as bone formation and 
resorption, are likely to contribute most strongly to these results. 
 Normal cortical (outer) bone porosity ranges from 10-30% while trabecular (inner) bone 
porosity ranges between 30-90% [39]. While cortical bone functions primarily in a load-bearing 
role, trabecular bone also acts to maintain blood calcium homeostasis and serves as a marrow 
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microenvironment for blood cell production [40]. Pore space is critical for maintaining these 
processes in addition to material transport, and is carefully balanced through osteoblast-led 
formation and osteoclast-controlled bone resorption [41]. Imbalances of either can lead to 
osteopetrosis or osteoporosis [42], respectively. In this study, starting with the empty hole of the 
induced defect, insertion of the hydroxyapatite scaffold immediately increased the porosity to 
50% before any bone could form. As evidenced from this study (Figure 2.5) and others [43,44], 
hydroxyapatite degrades slowly in a physiological environment, on the order of months to years 
before conversion to the more soluble β-tricalcium phosphate. Therefore, a maximum bone 
volume fraction of 0.4 (Figure 2.3) or a maximum percent bone fill of 80% (Figure 2.4) could be 
expected to achieve a final combined porosity of 10%, which is the minimum for cortical bone. 
In this study, the scaffold was inserted into the ramus of the mandible, which contains a lateral 
cortex, inner trabecular bone, and a medial cortex, all with different target porosities depending 
on location and site  [39]. Therefore, the amount of bone formation for the entire scaffold before 
a general equilibrium is established could be a weighted average of these tissues.  
 Based on the data in Figures 2.3 and 2.4, a general equilibrium between bone formation 
and resorption appears to be established for all treatments between 24 to 48 weeks. For this 
scaffold design, further bone formation may be limited by material transport [45] or mechanical 
stiffness in accordance with Wolff's Law [46]. Equilibrium has positive implications for this 
scaffold design for the purposes of tissue engineering, as one goal of this field is to create stable 
scaffolds with good biocompatibility with surrounding bone [47]. However, the brittle nature of 
hydroxyapatite and long-term nature of its physiological degradation (Figure 2.7) may currently 
limit its clinical utility [48]. 
 Future studies should examine macroscale behavior on longer timescales (2 or more 
years) to examine the process by which scaffold material is slowly removed and replaced by 
bone. Because this effect is generally on a smaller scale, higher resolution (<10 µm) may be 
necessary to observe changes in scaffolds over time. In addition, analysis of the differences 
between cortical and trabecular bone may play a key role for determining the target amounts of 
bone and scaffold on the macroscale. Another important aspect was the soft tissue, which micro-
CT cannot resolve compared to bone and scaffold material without special staining procedures 
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[49]. Finally, changing the concentration of BMP-2 may be necessary to ensure that its amount is 
not a limiting factor. 
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CHAPTER 3                                                                                                              
MICROSCALE ANALYSIS  
3.1 Overview 
This chapter details the histological preparation process, staining procedures, and 
protocol for light and electron microscope analysis in order to examine the cellular interactions, 
bone quality, and hydroxyapatite degradation in the micropores of the scaffold. Similar to the 
macroscale study, three scaffold types were compared, including empty HA controls, HA 
scaffolds with empty collagen microspheres, and HA scaffolds with collagen microspheres 
loaded with BMP-2. Time points were of 6, 12, 24, and 48 weeks post-surgery. Findings include 
the presence of important biological components surrounding the scaffold, including blood 
vessels, osteoclasts, mineralized bone tissue and adipocytes. A significant increase in 
microporosity was observed, which appeared to be reduced by the addition of growth factor. 
Bone fill into the micropores also increased with the addition of BMP-2. It is likely that these are 
explained by BMP-2 supplying a stronger stimulus for mesenchymal stem cells and 
osteoprogenitors to migrate and differentiate inside the scaffold micropores. This additional bone 
may then act to reduce surface area, lessening available surface area for osteoclast resorption and 
dissolution of the scaffold, resulting in more scaffold material being retained over time. 
3.2 Methods 
3.2.1 Histological sample preparation 
After micro-CT scanning, a total of 3 harvested scaffolds per treatment per time point 
(n=3) were trimmed using a band saw if necessary. Scaffolds and surrounding bone were fixed in 
10% neutral buffered formalin for two weeks, dehydrated in an ethanol series (70, 80, 90, 100%) 
and infiltrated with methylmethacrylate (MMA, Acros Organics, New Jersey) liquid monomer. 
Following addition of PMMA solid beads and benzoyl peroxide inducing polymerization, 
Samples were considered embedded in poly-methylmethacrylate (PMMA)  [32]. Following 
embedding, samples were sectioned parallel or perpendicular to the long axis of the cylinder 
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using a Buehler Isomet 100 diamond saw (Buehler, Lake Bluff, IL) to yield 500 µm thick 
sections, which were affixed to acrylic slides. Sections were polished to 150 μm thickness with 
increasing grades of silicon carbide sandpaper.  
3.2.2 Histological staining 
Sections were stained with Sanderson’s Rapid Bone Stain (Dorn & Hart Microedge, 
Chicago, IL) and counterstained with acid fuchsin. Control, unimplanted sections were prepared 
in the same manner. Briefly, Sanderson’s Rapid Bone Stain (as supplied) was heated to 55-60°C 
and sections on acrylic slides were stained for 4 minutes. Following staining, samples were 
rinsed in55-60 °C de-ionized water and blotted with a Kim-wipeTM to dry. Samples were then 
counterstained with 1% acid fuchsin (1 mL concentrated acetic acid, 1 g acid fuchsin powder, 99 
mL de-ionized water). Staining was for 2 minutes and 40 seconds, and samples were then again 
blotted with a kim-wipe to dry. If the staining was found to be too dark it was lightened with dips 
in 70% ethanol. 
3.2.3 Light Microscopy Imaging 
Sections were imaged using an IX51 light microscope (Olympus, Center Valley, PA). 
Imaging procedure entailed capturing all areas of the scaffold using multiple images under 40x 
magnification. Then, samples were examined at higher magnification and images were captured 
in areas of cell interaction with the scaffold, where scaffold stained positive for bone, or other 
notable areas on the slide. 
3.2.4 Electron Microscopy Sample Preparation 
 If necessary, samples were de-stained with 70% ethanol overnight. In order to fit samples 
in the Beckman ESEM, acrylic sections were cut so that only the section with the scaffold 
remained. Samples were stored in a dehydration chamber overnight at the Beckman Institute 
Imaging Technology Group before further processing. Samples were taped to SEM stands and 
placed in the Beckman Sputter Coater. After applying a 50 mbar vacuum and inducing eccentric 
rotation, samples were sputter coated with gold-palladium (Au-Pd) for 65 seconds (~11 nm 
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thick). Additionally, area surrounding the scaffold was coated with a layer of silver paint to 
allow for an electrically conducting surface to dissipate charge from the electron beam. 
3.2.5 Electron Microscope Imaging 
 After inducing a 1.3 x 10-4 mbar vacuum and making proper corrections for focusing and 
lens astigmatism, samples were imaged in backscatter electron mode using a Phillips XL30 
ESEM-FEG (FEI Company, Hillsboro, OR). Ten representative images were taken of each 
scaffold at 500x magnification (n=2 per treatment per timepoint). Beam voltage was 15 kV with 
a spot size of 4. Contrast and brightness were adjusted to maximize differences between scaffold 
(white), PMMA background (black), and bone (intermediate, grey). Images were saved as 8-bit 
TIFFs. 
3.2.6 Analysis of Light Microscope Images 
Light microscope images at 40x magnification were analyzed using the image analysis 
program, ImageJ (National Institutes of Health, Bethesda, MD). Circular rod sections in each 
histology sample were used for cell counting and measurement of stained area from both central 
rods and rods at the perimeter. 6-10 rods were randomly selected by a blinded, unbiased observer 
and analyzed. Red stained area was identified using the color threshholding tool. Three samples 
per time point per treatment (n=3) were analyzed. Values were calculated as follows: 
 
Fraction Scaffold Stained  = Area of red staining per total scaffold area 
     = (red area) / (total scaffold area) 
3.2.7 Analysis of Electron Microscope Images 
 Electron microscope images at 500x magnification were analyzed using the image 
analysis program, Image Pro Plus (MediaCybernetics, Bethesda, MD). A total of 10 images of 
scaffold rods containing bone in the micropores were analyzed for a total of 2 scaffolds per 
treatment per timepoint). Scaffold rod sections were defined as regions of interest. A histogram 
of pixel values (0-255) was displayed and an unbiased observer blinded to treatment and time 
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point manually threshholded the pixels into background (low, black), bone (intermediate, grey) 
and scaffold (high, white). Pixels in groups were summed and results were calculated as follows: 
 
Scaffold Microporosity  =  space which is not occupied by scaffold rods 
     =  1 – (scaffold pixels) / (total pixels) 
Fraction Micropore Bone  = Fraction of available space filled with bone 
     = (bone area) / (bone + background) 
3.2.8 Statistical Analysis 
Quantitative data are presented as mean ± standard error. Two-way analysis of 
variance (ANOVA) was performed using SAS statistical analysis software (SAS Institute, Cary, 
NC). Tukey’s test was used for pairwise mean comparisons. A total of 2 scaffolds per treatment 
per timepoint (n=2) were analyzed for a total of 24 scaffolds (N=24). Significance was evaluated 
using an alpha value of 0.05. 
3.3 Results 
3.3.1 General Histological Findings 
 General findings for all time points and treatments are shown in Figure 3.1. Mineralized 
bone stained red while non-mineralized collagen (soft tissue) stained blue. Cell nuclei from 
osteocytes, osteoblasts, and osteoclasts stained dark blue. Scaffolds generally remained unstained 
with periodic red spots, presumably bone in the micropores. Cell nuclei were also found in the 
micropores. Multi-nucleate osteoclasts were located on the scaffold with limited red staining 
nearby, indicating likely osteoclast resorption of the scaffold. Adipocytes, normally present in 
bone marrow, were also located near the scaffold and surrounding bone. Veins and arteries, 
essential for sustainable bone development, were also regularly observed in the scaffold. 
3.3.2 Light Microscope Images 
 Representative images for all treatments and time points are shown in Figure 3.2. 
Mineralized bone was present in all scaffolds, to varying degrees and locations. Bone tended to 
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be greater on the perimeter than at the center. Soft tissue often did not stay intact during 
histological processing, so it could not be quantified 
3.3.3 Fraction Scaffold Stained 
 Results of threshholding for red-stained (mineralized bone) sections of the scaffold are in 
Figure 3.3. Though this method resulted in higher variation than similar methods, a significantly 
higher fraction was noted with BMP-2 compared to empty HA scaffolds at week 12. Interaction 
was not significant between treatment and time point, and no differences were found between 
treatments over time. 
3.3.4 Scanning Electron Microscope Images 
 Representative images for all treatments and time points are shown in Figure 3.4. 
Scaffolds appeared white in color and area tended to decrease over time for all treatments, 
though the effect was stronger in empty HA scaffolds. The amount of bone (grey) did not appear 
to change over time while there appeared to be more in the scaffolds with BMP-2. 
3.3.5 Microporosity 
 Results of image analysis for microporosity are displayed in Figure 3.5. Microporosity 
significantly increased (p < 0.05) compared to non-implanted controls. Empty HA scaffolds were 
significantly higher (p < 0.05) at weeks 12 and 48. Interaction between treatment and time point 
was not significant.  
3.3.6 Fraction Micropore Bone Fill 
 Results of image analysis for the fraction of micropore space filled with bone is shown in 
Figure 3.6. More bone filled the micropores in the BMP treatment compared to empty HA 
scaffolds in weeks 6, 12, and 48 (p < 0.05). Interaction between treatment and time point was not 
significant. No differences were observed for any of the treatments over time.
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                            3.1a              3.1b 
     
                           3.1c             3.1d 
    
     3.1e            3.1f 
Figure 3.1: General histological findings. (a) Bone stains red, while soft tissue and cells stain blue. 
Scaffolds are generally unstained with likely red bone in micropores. (b) Bone interfaces well with 
the scaffold; cells are also found in the micropores. (c) Osteoclasts are found on the scaffold, 
indicating likely resorption. (d) Adipocytes, found in bone marrow, were also found near scaffold 
and bone. (e,f) Veins and arteries, essential for bone tissue ingrowth, are located within the scaffold. 
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Figure 3.2: Representative light microscope images. Bone was present inside the scaffold for all 
treatments. Soft tissue varied in thickness across samples, which often did not survive histological 
processing. 
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Figure 3.3: Fraction scaffold stained red showed little change for empty HA scaffolds and empty 
collagen microsphere treatments. BMP-2 treatment was significantly higher than empty HA at 
week 12. A significant difference between weeks 6 and 12 was observed for the BMP treatment.       
* p < 0.05. 
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Figure 3.4: Scanning electron microscope, backscatter mode images. Scaffold area (white) appeared 
to lessen over time for all treatments, though the effect was more pronounced for HA controls. 
Amount of bone (grey) showed little change over time compared to background (PMMA, black) for 
all treatments. 
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Figure 3.5: Microporosity significantly increased compared to non-implanted controls for all 
treatments and timepoints. Empty HA scaffolds had significantly higher microporosity at 12 and 48 
weeks. No significant changes were observed over time for any of the treatments. Interaction 
between treatment and time point was not significant. * p < 0.05. 
 
 
Figure 3.6: Percent micropore bone fill was significantly higher in BMP-2 treated scaffolds than 
empty HA scaffolds at 6, 12, and 48 weeks. No significant changes were observed over time for any 
of the treatments. Interaction between treatment and time point was not significant. * p < 0.05. 
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3.4 Discussion 
 In contrast to the macroscale study in Chapter 2, addition of BMP-2 to hydroxyapatite 
scaffolds appears to improve bone fill inside the micropores of the scaffold (Figure 3.6). This 
result, obtained from SEM image analysis, is in agreement in trend with the fraction scaffold 
stained data from light microscopy (Figure 3.4). However, SEM may provide an underestimate 
of the amount of bone due to uncertainty in pixel values between bone and scaffold thresh 
holding. On the other hand, scaffold staining fraction is likely to be an overestimate due to the 
chemical similarity of bone to the hydroxyapatite scaffold [50]. The strong osteoinductive effect 
of BMP-2 may promote mesenchymal stem cell migration to more locations on the scaffold and 
deeper inside the micropores of the scaffold rods [32].  
 The majority of bone was primarily located near the scaffold interface, likely due to 
material transport limitations. This additional bone would not only serve to help toughen this 
normally brittle ceramic  [51], but may also help to slow degradation (Figure 3.5). Osteoclasts 
were observed on the scaffold (Figure 3.1), which act to speed dissolution by creating an acidic 
microenvironment. Because osteoclasts require a contacting surface [52], it is possible that bone 
within micropores reduces surface area available for osteoclast resorption. The effect this would 
have on hydroxyapatite conversion to tricalcium phosphate and subsequent dissolution is 
currently unclear, though it may reduce exposure to body fluids, which may act to slow 
dissolution. Microporosity values agree with original compositional analysis. It is likely that the 
18% tricalcium phosphate which formed during fabrication was the first material to be removed 
due to its significantly higher dissolution rate.  
 However, sampling bias may be present in these results due to the requirement of 
histological sectioning. Efforts to cut the sections exactly perpendicular to scaffold struts were 
unsuccessful due to differences in scaffold placement, visual obstruction due to the fracture 
callus, and tolerances of the diamond blade. In addition, possible differences in the surrounding 
cortical and trabecular bone we not evaluated in this study. Due to the requirement of polishing 
sections, soft tissue generally did not survive histological processing, so although important 
components of bone physiology, such as veins, arteries and collagen, were observed (Figure 3.1), 
quantitative histomorphometric measurements could not be made.  
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 Future histological methods to study these scaffolds should attempt to preserve soft tissue 
for quantitative study. Due to the porous nature of the scaffold, thick sections (>200 µm) must be 
cut with limited tearing of the soft tissue away from the hard scaffold, which is difficult with 
current standard histological methods. In addition, a more quantitative method of threshholding 
the SEM images would be ideal. Current limitations with this imaging method, such as electronic 
charging of the PMMA embedding material and uniformity of gold-palladium coating thickness, 
makes a more exact approach, such as histogram curve fitting [25], difficult to achieve in 
practice. Taking into account these limitations, we conclude that addition of rhBMP-2 into a 
porous hydroxyapatite scaffold may be advantageous due to improved osteointegration on the 
microscale. 
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CHAPTER 4                                                                                                                       
SUMMARY AND CONCLUSIONS 
  
This thesis evaluated the in vivo suitability of porous hydroxyapatite scaffolds eluting 
rhBMP-2 for bone reconstruction in the mandible using the Yorkshire pig as a preclinical animal 
model. Release of growth factor was controlled using gelatin microspheres of a controlled 
diameter, providing an initial burst and sustained release of the growth factor. Treatments of 
empty HA scaffolds and HA scaffolds with empty gelatin microspheres were compared with HA 
scaffolds with gelatin microspheres infused with rhBMP-2 over 6, 12, 24, and 48 week time 
points. Osteointegration and degradation of the scaffold was assessed on the macroscale using 
micro-computed tomography and the microscale using light microscope histology and scanning 
electron microscopy.  
 Results included limited differences in bone and scaffold amounts between treatments on 
the macroscale. Bone formation was observed to proceed from the outside towards the center 
similar to the natural healing process. The center of the scaffold generally had limited bone 
ingrowth likely due to material transport limitations. However, significant increases in bone 
infiltration into scaffold micropores with the rhBMP-2 treatment could be observed on the 
microscale. Compared to non-implanted controls, significant degradation of the scaffold due to 
the physiological environment could be observed. This effect was more pronounced for the 
empty HA scaffolds possibly due to increased exposed surface area, resulting in increased 
osteoclast access to the scaffold, increased dissolution of β-tricalcium phosphate, and potentially 
increased conversion of hydroxyapatite to tricalcium phosphate. Increased bone infiltration and 
decreased scaffold degradation using BMP-2 infused scaffolds may provide a toughening 
mechanism for normally brittle hydroxyapatite, which is one its largest drawbacks for load-
bearing tissue engineering applications.  
 To improve clinical utility, future studies will examine the use of these scaffolds in a 
critical-size defects which do not heal naturally on their own (greater than 25 mm diameter) in 
the jaw. In addition, methods of matching the typically irregular geometry of patient defects with 
the production of matching irregularly shaped scaffolds are currently being investigated. From a 
more basic science perspective, the mechanism of mesenchymal stem cell migration to HA 
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scaffolds with gradients of growth factors such as BMP-2 is also currently unknown. In vitro 
culture experiments examining their migration over time would be help to elucidate these 
mechanisms, including changes in gene expression. Though much more work is required, tissue 
engineering strategies have a promising future as an alternative to current bone grafting methods. 
 Histological methods as used in this study, though destructive and two-dimensional, 
provided substantial information about microscale bone formation, currently unobtainable using 
non-destructive imaging methods. Used in combination, imaging and histological methods 
provide accurate assessment of macroscale and microscale attributes, respectively, to determine 
osteointegration and scaffold degradation. These metrics are essential for evaluation of the 
suitability of bone tissue engineering scaffolds. We conclude that addition of rhBMP-2 into a 
porous hydroxyapatite scaffold may be advantageous due to improved osteointegration on the 
microscale. 
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APPENDIX A                                                                                                           
PROTOCOLS 
A.1 Micro-CT Image Segmentation 
1. Beckman Imaging Laboratory computers with available power to run code (you can use more 
than one if it is not too busy in the lab) 
Pollock 
Keaton 
Arbus 
2. Be sure to sign up as soon as possible beforehand. 
http://itg.beckman.illinois.edu/calendars/index.htm#ms 
3. Check that the scaffold is properly rotated. Open W:\ajwj-ctdata\Aaron then open files to get 
the scaffold you need to measure. Double click on the scaffold labeled as “final” 
Amira will take time to load. Click on green bubble with the name of the scaffold. In the 
orange/yellow buttons, click orthoslice. 
4. Ensure that orthographic icon at top of screen has an eye with parallel bars     
Scroll through slices using slice number    Scaffolds should be 
relatively parallel and perpendicular, like this:            but not this:     
    
If a scaffold is not parallel, within about 1-2 degrees, mark it down in the log, so 
that it can be adjusted. 
5. Crop out incomplete regions and empty space 
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Starting from slice 0, slowly move slider to right (use arrows for small changes) until 
complete scaffold appears. Record this slice number.  
For example, incomplete1 = 0 to 55 
6. Move slider all the way to the right, then slowly move back to the left until complete scaffold 
appears. Record this slice number.  
For example, incomplete2 = 695 to 822 
7. Click on green box with filename 
Click on the crop tool   
8. Make sure the pointer is selected  
Move box out of way and click and drag green boxes so that about 1 inch of black space 
is remaining from the edge of the scaffold. Notice how the x and y coordinates change as 
you drag it left and right (x) and up and down (y) 
9. Click on orange Orthoslice box to check if all slices remain in crop box. If not, widen the box. 
 
10. Then, type in numbers for incomplete slices into the z box   lower number is on the top and 
smaller is on the bottom. 
11. Click OK. Scaffold will be cropped. Click on Orthoslice and slide through to double check. If 
any part of the complete scaffold got cropped out, quit amira and re-start 
12 Save Data into 2-D Tiff images 
Click on green box with filename. 
File -> Save Data As… -> W:/ajwj-ctdata/Aaron and get to file of the scaffold. 
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13. Create new folder, call if Tiff seg ready 
Double-click on new folder 
14. In bottom right corner, save files as 2-D Tiff 
Name file “seg ready_#-##-##” with today’s date 
Repeat these steps for 4 other scaffolds from the same treatment group. 
 
Prepping for Matlab 
1. Open Matlab 
2. Click on “….” To the right of Current Directory. Go to W:/ajwj-ctdata/Aaron 
Copy 8 matlab files (.m) into the current folder with the seg ready tif images 
These are: autoseg3, autothresh, batch_seg, get_cylinder, label_image, toughfix, 
paramget, simplefeatures 
3. Click again on “…” by Current Directory and open the Tiff seg ready folder for the scaffold 
you are working on. 
4. Paste these 8 files into the same folder along with the collection of images 
 
Matlab Code 
1. Note: Matlab can run 3-5 windows independently. So for each group of scaffolds, you could 
potentially do all 5 at one time 
2. "Rough" Matlab segmentation: batch_seg() 
Will take about 5 seconds a slice (1-1.5 hours per scaffold) 
3. “Refined” Matlab segmentation: simplefeatures()  
script should be in the same folder as the original stack of tiffs, along with paramget.m. 
No input is needed. 
4. creates the folder "eightfeatures”  
Will take about 5 seconds a slice (1-1.5 hours per scaffold) 
5. Repairing code difficulties (transition slices, broken pieces) 
toughfix(‘W:\ajwj-ctdata\Aaron\timepoint\scaffold\Tiff seg ready #\eightfeatures\’) 
Be sure to use single quotations before and after entire ‘pathname’ 
Script should be in the same folder as the original stack of tiffs 
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6. You can copy the text from the Current Directory at the top to save typing but needs the 
complete path upto and including the folder ‘eightfeatures\’ 
  creates the folder "tricky fix" which has the final segmentation 
Note: You must go up one folder for the code to work. 
Time to run is 0.25 seconds per slice (1-3 minutes per scaffold) 
 
Amira 
1. Load the stack of tiffs from the "trickyfix" folder 
2. Right-click on green bubble -> labeling ->  "label field"  
 threshold for the value "2" (the scaffold) using the sliders 
 hit "select" 
 in the top menu go to "selection"---"grow"---"all slices"   ------> do this twice 
 hit the plus button   to make that selection permanent 
  make sure the "all slices" bubble is checked 
  go back to the main Amira menu   
3. Right-click on the original data set that you loaded 
 go to "compute"----"arithmetic" 
 in the arithmetic box type "A*B" 
Right click on white box  connect "B" to the labels you just made 
 hit "apply"  
 this has now selected out the scaffold and border with their original values 
4. On the original data set that you loaded 
 go to "compute"---"arithmetic" 
 in the arithmetic box type "A-B" and connect "B" to the scaffold and border data that you 
  just created in Step 6 
 hit "apply"  
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 this has now created a data set of the labels for the bone and background, with  the border  
  around the scaffold removed 
 "save data as" Scaffoldnameandnumber_BoneBG_noBorder_values31 
5. On the labels of the scaffold and border from Step 5 
 go to "compute" ---- "arithmetic" 
 in the arithmetic box type "A*2"  
 hit "apply" 
 this give all of the voxels you selected previously the same value - "2" 
 "save data as"     Scaffoldnameandnumber_ScaffoldBorder__value2 
 
6.  On the original scaffold and the result you just made in Step 8 
 go to "compute" --- "arithmetic"  
in the arithmetic box type "A+B" and connect "B" to the scaffold and border data that 
 you just created in Step 8 
 hit "apply" 
 now you have all three materials together, but with the scaffold enlarged to include a  
  border  
 "save data as"  
7. Scaffoldnameandnumber_ThreeMaterials_GrownScaffold_CountandInterface 
  this needs to be saved as both a  "*.am" and 2-D "*.tif" file 
  put the tif stack in a brand new folder – call it Count_Interface 
 
Matlab 
1. Make sure that in the new folder with the tifs you just made the following 2 scripts are there 
(can get from the main Aaron folder) Amira Thresh folder to 
 interface_scaffold 
 interface_bone 
2. In the command window run each of the files (will take about 5 minutes for each) 
interface_scaffold()  
interface_bone() 
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 each script creates two folders; one contains tiffs of the interface of the materials and the  
  other contains tiffs of the outside of the material 
 copy and paste the three values that each script outputs into the “Region Calculator”  
  spreadsheet 
 interface_scaffold() 
3. Total Scaffold 
 Total Scaffold Outside 
 Total Scaffold Interface 
 interface_bone() 
4. Total Bone 
 Total Bone Outside 
 Total Bone Interface 
Note: The "outside" and "interface" values are really the most important, we'll get a 
volumetric measurement of the total bone from Amira in the next step 
 
Amira 
1. Load Scaffoldnameandnumber_ThreeMaterials_GrownScaffold_CountandInterface (the 
border will be taken out of the scaffold made its own material) 
2. Go to "label field" 
 threshold for "2" (scaffold)  
hit "select" 
 hit the plus button 
 return to the main menu 
 you now have the scaffold and border with a grayscale value of "1" 
 "save data as" Scaffoldnameandnumber_scaffoldborder_values1 
3.  Go to Main Menu- On the 
Scaffoldnameandnumber_ThreeMaterials_GrownScaffold_CountandInterface 
  "label field" 
  threshold for "2" (scaffold) 
  hit "select" 
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  on the top menu bar "Selection"---"Shrink"--- "All Slices"  
  shrink it twice 
   hit the plus button 
  return to the main menu 
  you now have the scaffold with a grayscale value of "1" 
 "save data as" Scaffoldnameandnumber_scaffold_value1 
4. On the Scaffoldnameandnumber_scaffoldborder_values1  labels that you made in Step 16  
 "compute"---"arithmetic" 
 in the arithmetic box type "A-B" (labels – labels 2) and connect "B" to  
  Scaffoldnameandnumber_scaffold_value1 that you made in step 17 
 hit "apply" (result 1) 
Note: you now have the border region with values of "1", but you don't want "1" because 
that's what the background is 
5.  On the border labels you just made in Step 18 (result 1) 
 "compute" --- "arithmetic" 
 in the arithmetic box type "A*4" 
 hit "apply" (result 2) 
 you now have the border region for half the scaffold with the correct values 
 "save data as"  Scaffoldnameandnumber_Border_value4 
6.  On the Scaffoldnameandnumber_scaffold_value1 (from step 17 Labels 2) 
 "compute" ---"arithmetic" 
 in the arithmetic box type "A*2"  
 hit "apply" (result 3) 
 (you now have the scaffold region with the correct values) 
 "save data as" Scaffoldnameandnumber_Scaffold_value2 
Note: you can make the bubble box bigger if needed and commands you use often will 
automatically appear at the top of it. 
7.  On Scaffoldnameandnumber_scaffoldborder_values1 (from step 16 Labels 1) 
 "compute" ---  "arithmetic" 
 in the arithmetic box type "A*2" 
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 hit "apply" (result 4) 
 (you now have the scaffold and border region with a value of "2" for half the scaffold) 
8.  On Scaffoldnameandnumber_ThreeMaterials_GrownScaffold_CountandInterface 
 "compute" --- "arithmetic" 
 in the arithmetic box type "A-B" and connect "B" to the labels you just made in Step 21  
  (result 4) 
 hit "apply" (result 5) 
  (you now have just the Bone and Background with their proper values 
9.  On the data you just made (result 5) 
 "compute"---"arithmetic" 
 in the arithmetic box type "A+B+C"  
  connect "B" to Scaffoldnameandnumber_Scaffold_value2 (result 3) 
  connect "C" to Scaffoldnameandnumber_Border_value4 (result 2) 
 hit "apply" 
  (you now have the half scaffold with all four materials and their proper values) 
 "save data as" Scaffoldnameandnumber_4materials 
10. Now, you are going to subdivide scaffold slices into 3 regions (cortical1, trabecular,cortical2) 
Select Scaffoldname_4materials -> OrthoSlice 
  Drag slider all the way to the right and record total number of slices 
Use Excel spreadsheet “ Region Calculator” to enter number of slices into yellow box  
be sure to also record scaffold number for later reference 
  Notice beginning and ending slices for each region 
 Select Scaffoldname_4materials 
  Select Crop tool 
 For the two boxes on the far right, enter in the slices for the region to analyze 
(smaller number on top) 
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11.  On the data you just made in Step 24 
  Go to "label field" 
  threshold a material (you'll have to do all four separately) 
   hit "select" 
   hit the plus button - the material you selected is the "inside" 
   in the top menu bar go to "Segmentation" --- "Material Statistics" 
   make sure the "Materials" bubble is checked 
Copy and paste the Count" and value for the inside material in the Material Statistics  
    check that the volume value is the same as the count value 
   hit "close" (you are still in "label field", though) 
   change the threshold for another material and repeat until all are done 
   "0"  outside area around the scaffold (we don't need this information) 
   "1" Background 
   "2" Scaffold  
(Note: depending on slice, most of the scaffold could be considered border; that is okay) 
   "3" Bone 
   "4" Border  
12. Close out all bubbles -> DO NOT save the cropped scaffolds 
 Re-open Scaffoldname_4materials 
13. Repeat cropping for both the trabecular and cortical regions (two more times) 
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A.2 Scaffold Histomorphometry 
Objectives: 
A. Count cells on scaffold (blue spots) 
B. Quantify amount of red space (bone) on scaffold 
 
 
A. Counting Cells on scaffold 
1. Zoom in on area of interest 
 with your pointer on area, you can use “+” and “-“ buttons to zoom in/out  
 or, box selection with square button, then Image -> Zoom -> to selection 
2. Use point selection tool to count cells 
 7th from right, hold shift + click for multiple points 
3. Count cells in the area of interest 
 defined as dark blue staining of nucleus 
 be as consistent as possible between samples, using approximately same zoom settings 
4. Analyze points counted 
 Analyze -> Measure 
 The total count is the only number of interest 
5. Zoom out to original size and repeat until all cells on scaffold have been counted 
 When one image is completed, record number in spreadsheet 
Scaffold 
Bone in 
scaffold 
 
Bone 
(Red) 
Soft tissue 
(pulled away) 
Cells 
(blue) 
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B. Quantifying red space (bone) on the inside of the scaffold 
1. First open the 4x scale bar to calibrate the correct distances 
 Draw line (make sure it’s straight) from end to end of scale bar 
Analyze -> Set Scale, enter 1000 for known distance and change units to um (micrometers) -> 
check global and click ok 
2. Open picture for analysis, do this twice 
 For one of the pictures, Image -> Color -> Split channels 
Compare black and white pictures with original color, the best one will have high  
contrast between red and the surrounding area (i.e. red appears the blackest).  
Typically, this is the green channel but due to quality of stain, not always 
3. Threshhold image with highest contrast 
 Image -> Adjust -> Threshhold 
 Drag upper bar so that is almost entirely to the left 
Drag lower bar until red threshholded area is relatively close to the same pattern in the original 
picture; as a clue, surrounding bone should  be relatively filled in 
 When satisfied, click apply. 
Note: due to differences in staining, camera lighting, etc. this might not work the best sometimes; 
just make a good faith effort, as there’s some experimental error in this procedure 
4. For non-threshholded channel, use freehand selection (4th from left) and trace an area of the 
scaffold of interest 
 Analyze -> Measure 
 On results tab, Edit -> Set Measurements 
  Check boxes for “Area” and “Area Fraction” 
5. Then, for same scaffold area on threshholded scaffold, use freehand selection to select 
relatively similar scaffold area 
Keep a system to keep these two measurements straight 
  For example, odd = total scaffold, even = red space on scaffold 
6. Repeat steps 4 and 5 until all scaffold area has been measured 
7. On results tab, Copy  
8. Paste into Excel spreadsheet 
